ArticleJournal of clinical medicine2022

BeEAM High-Dose Chemotherapy with Polatuzumab (Pola-BeEAM) before ASCT in Patients with DLBCL-A Pilot Study.

Tanja Stoffel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.